Drug Trial Radar · NCT05747430
SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF)
Last checked: Nov 19, 2026Latest source record: Apr 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
155
Actual
Start
Feb 22, 2023
Primary completion
Mar 6, 2025
Study completion Mar 31, 2026
Sponsor
- Lead sponsor
- iRenix Medical, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 28, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a randomized, double-masked study to evaluate the tolerability and safety of IRX-101 versus 5% povidone-iodine (PI) in subjects receiving intravitreal anti-VEGF injections. The study will be conducted in up to 15 centers in the United States (US).
Conditions
- Retinal Disease
Interventions
IRX-101Drug
IRX-101 is a novel ocular anti-septic
Providone-IodineDrug
5% Providone-Iodine
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety of new drugTime frame: 1-hour and 1-week post-treatment
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Coastal Eye Surgeons, LLC
Greenwich, Connecticut
Mississippi Retina Associates
Madison, Mississippi
Erie Retina Research, LLC
Erie, Pennsylvania
Charleston Neuroscience Institute
Ladson, South Carolina
Retina Consultants of Texas
Katy, Texas
Edward Wood, MD
Round Rock, Texas
Retina Associates of Utah
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.